HEAR FROM OUR TENANTS

 

Click above to listen to some of
the SBC tenants

  • Latest News
  • ReViral Announces Good Safety and Pharmacokinetics From Phase 1 Progra

    Phase 2a RSV Challenge Study Planned for Q3 2017 London, UK, 24 th April 2017 / ReViral, a UK based biotechnology company focused on the discovery and development of antivirals for respiratory syncytial virus (RSV), announced today top-line safety and pharmacokinetic (PK) data from the Phase 1 single and... read more

INNOVATION PORTAL

Funding Partners: